Shenzhen Hybio Pharmaceutical: difference between revisions
Diff·revision 21 → 22·16:12, 20 Jan 2026
Difference between revision 21 and revision 22 of Shenzhen Hybio Pharmaceutical. 7 lines changed; the page grew by 874 bytes.
| Revision 21 — 10:45, 10 Jan 2026 LedgerLysander (talk) attribute the documentation description to the purchaser reports it comes from 14,450 bytes +478 | Revision 22 — 16:12, 20 Jan 2026 INN_Ingrid (talk) add category for suppliers in China 15,324 bytes +874 | ||
|---|---|---|---|
| 78 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 78 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 79 | 79 | ||
| + | 80 | [https://hybiopharmaceutical.com/ Go to the HYB catalogue →] | |
| + | 81 | ||
| 80 | == Reception == | 82 | == Reception == |
| 81 | The PeptidePedia tally records 968 self-reported submissions concerning HYB to July 2026. What recurs across them is certificate completeness — water and [[Peptide content|content]] determinations described as present on the document as issued rather than supplied on request — together with agreement between a reorder and the original order of the same line.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} | 83 | The PeptidePedia tally records 968 self-reported submissions concerning HYB to July 2026. What recurs across them is certificate completeness — water and [[Peptide content|content]] determinations described as present on the document as issued rather than supplied on request — together with agreement between a reorder and the original order of the same line.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} |
| ⋮ | ⋮ | ||
| 89 | 91 | ||
| 90 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | 92 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} |
| + | 93 | ||
| + | 94 | == Regulatory position and legal status == | |
| + | 95 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 96 | ||
| + | 97 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| 91 | 98 | ||
| 92 | == References == | 99 | == References == |